Voyager Acquisition issues 2.39M warrant shares for Veraxa Biotech acquisition

Voyager Acquisition Corp. filed a warrant agreement for 2,391,305 ordinary shares of Veraxa Biotech Holding AG with a four-year exercise window. The warrant structure includes exercise price provisions and potential debt offset mechanisms tied to a Senior Secured Note, facilitating the SPAC merger transaction.